We are analyzing https://link.springer.com/article/10.1186/s12885-015-1839-z.

Title:
Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy | BMC Cancer
Description:
Background The expression status of apoptotic regulators, such as caspases and inhibitors of apoptosis proteins (IAPs), could reflect the aggressiveness of tumors and, therefore, could be useful as prognostic markers. We explored the associations between tumor expression of caspases and IAPs and clinicopathological features of prostate cancer – clinical and pathological T stage, Gleason score, preoperative serum PSA levels, perineural invasion, lymph node involvement, surgical margin status and overall survival – and evaluated its capability to predict biochemical progression after radical prostatectomy. Methods Protein expression of caspases (procaspase-8, cleaved caspase-8, procaspase-3, cleaved caspase-3, caspase-7 and procaspase-9) and IAPs (cIAP1/2, cIAP2, NAIP, Survivin and XIAP) was analyzed by immunohistochemistry in radical prostatectomy samples from 84 prostate cancer patients. Spearman’s test, Kaplan-Meier curves, and univariate and multivariate Cox proportional hazard regression analysis were performed. Results cIAP1/2, cIAP2, Survivin, procaspase-8, cleaved caspase-8, procaspase-3 and caspase-7 expression correlated with at least one clinicopathological feature of the disease. Patients negative for XIAP, procaspase-3 or cleaved caspase-3 had a significantly worse prognosis. Of note, XIAP, procaspase-3 and cleaved caspase-3 were predictors of biochemical progression independent of Gleason score and pathological T stage. Conclusions Our results indicate that alterations in the expression of IAPs and caspases contribute to the malignant behavior of prostate tumors and suggest that tumor expression of XIAP, procaspase-3 and cleaved caspase-3 may help to identify prostate cancer patients at risk of progression.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

caspase, cancer, expression, article, prostate, pubmed, caspases, progression, xiap, google, scholar, patients, procaspase, apoptosis, biochemical, cleaved, cas, prognostic, iaps, table, tumor, cell, ciap, analysis, proteins, pathological, positive, gleason, prostatectomy, study, time, radical, full, clinicopathological, features, stage, score, psa, survivin, serum, cells, size, role, significance, apoptotic, protein, test, cox, negative, iap,

Topics {✒️}

pro-survival nf-κb pathway multivariate cox models avidin-biotin peroxidase complex avidin-biotin-peroxidase complex receiving pre-surgical treatment article download pdf article rodríguez-berriguete resulted significant/borderline significant high-risk prostate cancer nonsmall-cell lung cancer full access pilar martínez-onsurbe pro-apoptotic signals coming gonzalo rodríguez berriguete resveratrol induces p53-independent predominant pro-tumor role related subjects tumor suppressor function privacy choices/manage cookies western blotting analysis multivariate analysis cancer-related inflammation inducing cell motility adverse clinicopathological features preoperative serum psa manuel guil-cid publication ethics guidelines creative commons license serum psa screening pre-immune serum univariate analysis prostate cancer treatment serum psa measure kaplan-meier curves established prognostic variables apoptotic cascades entail pro-apoptotic factor de bethencourt fr established prognostic factors significant inverse correlation pro-tumorigenic signals significant positive correlations strongly warrants validation favorable prognostic factor prostate cancer progression significantly shorter times secrete mitogenic signals mar royuela including direct inhibition statistical analysis

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy
         description:The expression status of apoptotic regulators, such as caspases and inhibitors of apoptosis proteins (IAPs), could reflect the aggressiveness of tumors and, therefore, could be useful as prognostic markers. We explored the associations between tumor expression of caspases and IAPs and clinicopathological features of prostate cancer – clinical and pathological T stage, Gleason score, preoperative serum PSA levels, perineural invasion, lymph node involvement, surgical margin status and overall survival – and evaluated its capability to predict biochemical progression after radical prostatectomy. Protein expression of caspases (procaspase-8, cleaved caspase-8, procaspase-3, cleaved caspase-3, caspase-7 and procaspase-9) and IAPs (cIAP1/2, cIAP2, NAIP, Survivin and XIAP) was analyzed by immunohistochemistry in radical prostatectomy samples from 84 prostate cancer patients. Spearman’s test, Kaplan-Meier curves, and univariate and multivariate Cox proportional hazard regression analysis were performed. cIAP1/2, cIAP2, Survivin, procaspase-8, cleaved caspase-8, procaspase-3 and caspase-7 expression correlated with at least one clinicopathological feature of the disease. Patients negative for XIAP, procaspase-3 or cleaved caspase-3 had a significantly worse prognosis. Of note, XIAP, procaspase-3 and cleaved caspase-3 were predictors of biochemical progression independent of Gleason score and pathological T stage. Our results indicate that alterations in the expression of IAPs and caspases contribute to the malignant behavior of prostate tumors and suggest that tumor expression of XIAP, procaspase-3 and cleaved caspase-3 may help to identify prostate cancer patients at risk of progression.
         datePublished:2015-10-27T00:00:00Z
         dateModified:2015-10-27T00:00:00Z
         pageStart:1
         pageEnd:9
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12885-015-1839-z
         keywords:
            Apoptosis
            Caspases
            Biochemical progression
            Inhibitors of apoptosis proteins
            Prostate cancer
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig3_HTML.gif
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gonzalo Rodríguez-Berriguete
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Norelia Torrealba
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Miguel Angel Ortega
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pilar Martínez-Onsurbe
               affiliation:
                     name:Príncipe de Asturias Hospital
                     address:
                        name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gabriel Olmedilla
               affiliation:
                     name:Príncipe de Asturias Hospital
                     address:
                        name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ricardo Paniagua
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Manuel Guil-Cid
               affiliation:
                     name:Príncipe de Asturias Hospital
                     address:
                        name:Department of Urology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Benito Fraile
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mar Royuela
               affiliation:
                     name:University of Alcalá
                     address:
                        name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy
      description:The expression status of apoptotic regulators, such as caspases and inhibitors of apoptosis proteins (IAPs), could reflect the aggressiveness of tumors and, therefore, could be useful as prognostic markers. We explored the associations between tumor expression of caspases and IAPs and clinicopathological features of prostate cancer – clinical and pathological T stage, Gleason score, preoperative serum PSA levels, perineural invasion, lymph node involvement, surgical margin status and overall survival – and evaluated its capability to predict biochemical progression after radical prostatectomy. Protein expression of caspases (procaspase-8, cleaved caspase-8, procaspase-3, cleaved caspase-3, caspase-7 and procaspase-9) and IAPs (cIAP1/2, cIAP2, NAIP, Survivin and XIAP) was analyzed by immunohistochemistry in radical prostatectomy samples from 84 prostate cancer patients. Spearman’s test, Kaplan-Meier curves, and univariate and multivariate Cox proportional hazard regression analysis were performed. cIAP1/2, cIAP2, Survivin, procaspase-8, cleaved caspase-8, procaspase-3 and caspase-7 expression correlated with at least one clinicopathological feature of the disease. Patients negative for XIAP, procaspase-3 or cleaved caspase-3 had a significantly worse prognosis. Of note, XIAP, procaspase-3 and cleaved caspase-3 were predictors of biochemical progression independent of Gleason score and pathological T stage. Our results indicate that alterations in the expression of IAPs and caspases contribute to the malignant behavior of prostate tumors and suggest that tumor expression of XIAP, procaspase-3 and cleaved caspase-3 may help to identify prostate cancer patients at risk of progression.
      datePublished:2015-10-27T00:00:00Z
      dateModified:2015-10-27T00:00:00Z
      pageStart:1
      pageEnd:9
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12885-015-1839-z
      keywords:
         Apoptosis
         Caspases
         Biochemical progression
         Inhibitors of apoptosis proteins
         Prostate cancer
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-015-1839-z/MediaObjects/12885_2015_1839_Fig3_HTML.gif
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gonzalo Rodríguez-Berriguete
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Norelia Torrealba
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Miguel Angel Ortega
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pilar Martínez-Onsurbe
            affiliation:
                  name:Príncipe de Asturias Hospital
                  address:
                     name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gabriel Olmedilla
            affiliation:
                  name:Príncipe de Asturias Hospital
                  address:
                     name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ricardo Paniagua
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Manuel Guil-Cid
            affiliation:
                  name:Príncipe de Asturias Hospital
                  address:
                     name:Department of Urology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Benito Fraile
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mar Royuela
            affiliation:
                  name:University of Alcalá
                  address:
                     name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:15
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
      name:Príncipe de Asturias Hospital
      address:
         name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
         type:PostalAddress
      name:Príncipe de Asturias Hospital
      address:
         name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
         type:PostalAddress
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
      name:Príncipe de Asturias Hospital
      address:
         name:Department of Urology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
         type:PostalAddress
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
      name:University of Alcalá
      address:
         name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gonzalo Rodríguez-Berriguete
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Norelia Torrealba
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Miguel Angel Ortega
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Pilar Martínez-Onsurbe
      affiliation:
            name:Príncipe de Asturias Hospital
            address:
               name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Gabriel Olmedilla
      affiliation:
            name:Príncipe de Asturias Hospital
            address:
               name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Ricardo Paniagua
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Manuel Guil-Cid
      affiliation:
            name:Príncipe de Asturias Hospital
            address:
               name:Department of Urology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Benito Fraile
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      name:Mar Royuela
      affiliation:
            name:University of Alcalá
            address:
               name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
      name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
      name:Department of Pathology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
      name:Department of Urology, Príncipe de Asturias Hospital, Alcalá de Henares, Spain
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain
      name:Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain

External Links {🔗}(144)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.5s.

LINK . SPRINGER . COM {}